| Date Filed | Type | Description |
| 09/26/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 33,805 shares
@ $0
Disposed/sold 16,500 options to buy
@ $121.29, valued at
$2M
Disposed/sold 70,000 options to buy
@ $27.32, valued at
$1.9M
Disposed/sold 63,650 options to buy
@ $36.71, valued at
$2.3M
Disposed/sold 71,300 options to buy
@ $24.75, valued at
$1.8M
Disposed/sold 34,500 options to buy
@ $55.73, valued at
$1.9M
Disposed/sold 17,250 options to buy
@ $55.73, valued at
$961.3k
Disposed/sold 24,000 options to buy
@ $207.2, valued at
$5M
|
|
| 08/17/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 807 shares
@ $169.0367, valued at
$136.4k
Sold 398 shares
@ $168.3317, valued at
$67k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/10/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 4,125 shares
@ $0 |
|
| 06/02/2023 |
4
| Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 125,000 options to buy
@ $3.27, valued at
$408.8k
|
|
| 05/17/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 894 shares
@ $85.09, valued at
$76.1k
Sold 417 shares
@ $80.955, valued at
$33.8k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/15/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 9,317 shares
@ $86.77, valued at
$808.4k
|
|
| 03/08/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 48,370 shares
@ $0
Sold 40,134 shares
@ $89.3, valued at
$3.6M
Sold 14,820 shares
@ $90.26, valued at
$1.3M
Converted 41,630 shares
@ $0
Sold 36,049 shares
@ $85.08, valued at
$3.1M
Sold 5,793 shares
@ $85.9, valued at
$497.6k
Sold 200 shares
@ $86.67, valued at
$17.3k
Exercised 48,370 options to buy
@ $21.05, valued at
$1M
Converted 48,370 options to buy
@ $0
Exercised 41,630 options to buy
@ $21.05, valued at
$876.3k
Converted 41,630 options to buy
@ $0 |
|
| 03/06/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Sold 2,166 shares
@ $88.2491, valued at
$191.1k
|
|
| 01/04/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 15,675 shares
@ $0
Granted 63,650 options to buy
@ $36.71, valued at
$2.3M
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 35,000 shares
@ $0
Granted 70,000 options to buy
@ $27.32, valued at
$1.9M
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2020 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 60,000 shares
@ $0
Sold 30,000 shares
@ $150.01, valued at
$4.5M
Sold 30,000 shares
@ $175, valued at
$5.3M
Exercised 60,000 options to buy
@ $21.05, valued at
$1.3M
Converted 60,000 options to buy
@ $0 |
|
| 06/09/2020 |
4
| Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 83,000 options to buy
@ $1.54, valued at
$127.8k
|
|
| 01/06/2020 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 24,000 options to buy
@ $207.2, valued at
$5M
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 70,000 options to buy
@ $1.38, valued at
$96.6k
|
|
| 03/28/2019 |
4
| Bir Dawn Carter (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 120,000 options to buy
@ $1.68, valued at
$201.6k
|
|
| 03/28/2019 |
3
| Bir Dawn Carter (Director) has filed a Form 3 on GERON CORP |
| 01/03/2019 |
4
| Bir Dawn Carter (VP, Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 34,500 options to buy
@ $55.73, valued at
$1.9M
|
|
| 12/07/2017 |
4
| Bir Dawn Carter (VP, Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 71,300 options to buy
@ $24.75, valued at
$1.8M
|
|
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/31/2016 |
3
| Bir Dawn Carter (VP, Chief Commercial Officer) has filed a Form 3 on REATA PHARMACEUTICALS INC |